Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardian Pharmacy Services (GRDN) Assets (2023 - 2025)

Guardian Pharmacy Services' Assets history spans 3 years, with the latest figure at $412.7 million for Q4 2025.

  • For Q4 2025, Assets rose 28.63% year-over-year to $412.7 million; the TTM value through Dec 2025 reached $412.7 million, up 28.63%, while the annual FY2025 figure was $412.7 million, 28.63% up from the prior year.
  • Assets for Q4 2025 was $412.7 million at Guardian Pharmacy Services, up from $390.0 million in the prior quarter.
  • Across five years, Assets topped out at $412.7 million in Q4 2025 and bottomed at $271.2 million in Q4 2023.
  • The 3-year median for Assets is $348.0 million (2024), against an average of $347.6 million.
  • The largest YoY upside for Assets was 28.63% in 2025 against a maximum downside of 12.07% in 2025.
  • A 3-year view of Assets shows it stood at $271.2 million in 2023, then increased by 18.31% to $320.8 million in 2024, then increased by 28.63% to $412.7 million in 2025.
  • Per Business Quant, the three most recent readings for GRDN's Assets are $412.7 million (Q4 2025), $390.0 million (Q3 2025), and $356.3 million (Q2 2025).